Truist: 'We Continue To See Upside to Chemours (CC) Shares'
Tweet Send to a Friend
Truist Securities analyst Peter Osterland reiterated a Buy rating and $21.00 price target on Chemours (NYSE: CC).The analyst commented: "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
